|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Correa P: Diet and gastric cancer. Diet,
Nutrition and Cancer: A Critical Evaluation. Reddy BS and Cohen AL:
1. 1st. CRC Press; pp. 1–10. 2017
|
|
3
|
Oki E, Tokunaga S, Emi Y, Kusumoto T,
Yamamoto M, Fukuzawa K, Takahashi I, Ishigami S, Tsuji A, Higashi
H, et al Kyushu Study Group of Clinical Cancer, : Surgical
treatment of liver metastasis of gastric cancer: A retrospective
multicenter cohort study (KSCC1302). Gastric Cancer. 19:968–976.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee YC, Chiang TH, Chou CK, Tu YK, Liao
WC, Wu MS and Graham DY: Association between Helicobacter
pylori eradication and gastric cancer incidence: A systematic
review and meta-analysis. Gastroenterology. 150:1113–1124.e5. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JW, Nam KH, Ahn SH, Park DJ, Kim HH,
Kim SH, Chang H, Lee JO, Kim YJ, Lee HS, et al: Prognostic
implications of immunosuppressive protein expression in tumors as
well as immune cell infiltration within the tumor microenvironment
in gastric cancer. Gastric Cancer. 19:42–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamada T, Yoshikawa T, Taguri M, Hayashi
T, Aoyama T, Sue-Ling HM, Bonam K, Hayden JD and Grabsch HI: The
survival difference between gastric cancer patients from the UK and
Japan remains after weighted propensity score analysis considering
all background factors. Gastric Cancer. 19:479–489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the Task Force
of the Japanese Gastric Cancer Association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sahin U, Tureci O, Koslowski M, Walter K,
Woll S, Kreuzberg M, Hubner B and Erdeljan M: Antibodies specific
for claudin 6 (CLDN6). US Patent 9,487,584. Filed November 11,
2010; issued August 11, 2016.
|
|
10
|
Nelhűbel GA, Károly B, Szabó B, Lotz G,
Kiss A, Tóvári J and Kenessey I: The prognostic role of claudins in
head and neck squamous cell carcinomas Pathol. Oncol Res.
20:99–106. 2014. View Article : Google Scholar
|
|
11
|
Zhang WN, Li W, Wang XL, Hu Z, Zhu D, Ding
WC, Liu D, Li KZ, Ma D and Wang H: CLDN1 expression in cervical
cancer cells is related to tumor invasion and metastasis.
Oncotarget. 7:87449–87461. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rugge M, Fassan M and Graham DY:
Epidemiology of gastric cancer. Gastric Cancer. Strong VE: (1st).
Springer International Publishing. (Switzerland). 23–34. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sano T: Gastric cancer: Asia and the
world. Gastric Cancer. 20 Suppl 1:1–2. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Graham DY: Helicobacter pylori
update: Gastric cancer, reliable therapy, and possible benefits.
Gastroenterology. 148:719–31.e3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Merchant SJ, Kim J, Choi AH, Sun V, Chao J
and Nelson R: A rising trend in the incidence of advanced gastric
cancer in young Hispanic men. Gastric Cancer. 20:226–234. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arabzadeh A, Troy TC and Turksen K: Role
of the Cldn6 cytoplasmic tail domain in membrane targeting and
epidermal differentiation in vivo. Mol Cell Biol. 26:5876–5887.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang M, Li Y, Shen X, Ruan Y, Lu Y, Jin X,
Song P, Guo Y, Zhang X, Qu H, et al: CLDN6 promotes chemoresistance
through GSTP1 in human breast cancer. J Exp Clin Cancer Res.
36:1572017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Y, Lin D, Zhang M, Zhang X, Li Y, Yang
R, Lu Y, Jin X, Yang M, Wang M, et al: CLDN6-induced apoptosis via
regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells. Int
J Oncol. 48:2435–2444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maruyama K: The most important prognostic
factors for gastric cancer patients: A study using univariate and
multivariate analyses. Scand J Gastroenterol. 22 Suppl 133:63–68.
1987. View Article : Google Scholar
|
|
22
|
Torres-Martínez AC, Gallardo-Vera JF,
Lara-Holguin AN, Montaño LF and Rendón-Huerta EP: Claudin-6
enhances cell invasiveness through claudin-1 in AGS human
adenocarcinoma gastric cancer cells. Exp Cell Res. 350:226–235.
2017. View Article : Google Scholar : PubMed/NCBI
|
